A number of studies carried out in animal models of ischemia-reperfusion damage, cardiac hypertrophy and heart failure have shown that lower reverse-activity of NCX1 is associated with an improvement in diastolic function through prevention of intracellular calcium overload [53,54,55,56,57]. Here, SLC8A1 is linked to cardiac hypertrophy.